Company Quick10K Filing
Pfizer
10-Q 2020-03-29 Filed 2020-05-07
10-K 2019-12-31 Filed 2020-02-27
10-Q 2019-09-29 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-02-28
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-07-01 Filed 2018-08-09
10-Q 2018-04-01 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-02-22
10-Q 2017-10-01 Filed 2017-11-09
10-Q 2017-07-02 Filed 2017-08-10
10-Q 2017-04-02 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-02-23
10-Q 2016-10-02 Filed 2016-11-10
10-Q 2016-07-03 Filed 2016-08-11
10-Q 2016-04-03 Filed 2016-05-12
10-K 2015-12-31 Filed 2016-02-29
10-Q 2015-09-27 Filed 2015-11-05
10-Q 2015-06-28 Filed 2015-08-06
10-Q 2015-03-29 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-28 Filed 2014-11-06
10-Q 2014-06-29 Filed 2014-08-07
10-Q 2014-03-30 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-02-28
10-Q 2013-09-29 Filed 2013-11-08
10-Q 2013-06-30 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-02-28
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-07-01 Filed 2012-08-09
10-Q 2012-04-01 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-02-28
10-Q 2011-10-02 Filed 2011-11-10
10-Q 2011-07-03 Filed 2011-08-11
10-Q 2011-04-03 Filed 2011-05-12
10-K 2010-12-31 Filed 2011-02-28
10-Q 2010-10-03 Filed 2010-11-12
10-Q 2010-07-04 Filed 2010-08-12
10-Q 2010-04-04 Filed 2010-05-13
10-K 2009-12-31 Filed 2010-02-26
8-K 2020-05-29
8-K 2020-05-28
8-K 2020-05-22
8-K 2020-05-18
8-K 2020-04-28
8-K 2020-04-23
8-K 2020-04-01
8-K 2020-03-25
8-K 2020-03-03
8-K 2020-02-27
8-K 2020-02-27
8-K 2020-02-11
8-K 2020-01-28
8-K 2019-12-13
8-K 2019-10-29
8-K 2019-09-24
8-K 2019-07-31
8-K 2019-07-29
8-K 2019-07-29
8-K 2019-06-27
8-K 2019-06-14
8-K 2019-04-30
8-K 2019-04-25
8-K 2019-03-11
8-K 2019-03-04
8-K 2019-01-29
8-K 2018-12-19
8-K 2018-12-19
8-K 2018-12-07
8-K 2018-10-30
8-K 2018-09-27
8-K 2018-09-04
8-K 2018-07-31
8-K 2018-05-01
8-K 2018-04-26
8-K 2018-03-02
8-K 2018-02-22
8-K 2018-01-30

Pfizer Financials

PFE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Johnson & Johnson (JNJ) 345,690 66% 16.4 9% 155,521 97,311 81,706 54,323 14,151 21,578 354,665
Merck (MRK) 214,488 70% 18.9 9% 83,331 56,493 34,973 24,530 7,492 12,141 229,294
Pfizer (PFE) 207,742 81% 12.0 10% 170,446 105,051 39,062 31,451 16,629 20,353 243,371
GlaxoSmithKline (GSK) 200,316 0% 58,066 54,394 0 0 0 0 225,704
Novartis (NVS) 197,050 0% 145,563 66,871 0 0 0 0 193,929
Abbott (ABT) 150,169 59% 16.4 5% 67,887 36,586 31,904 18,673 3,687 10,019 164,168
AbbVie (ABBV) 109,786 77% 21.1 5% 59,441 67,667 32,867 25,412 3,255 6,259 132,264
Eli Lilly (LLY) 105,897 78% 12.7 21% 37,893 34,431 22,644 17,612 7,948 9,419 119,560
Beigene (BGNE) 100,124 74% -123.1 -44% 1,881 587 430 318 -827 -807 99,328
Bristol Myers Squibb (BMY) 82,160 70% 10.6 10% 57,433 39,679 24,173 16,837 5,680 7,151 76,061
Celgene (CELG) 72,111 96% 10.4 14% 41,363 29,276 16,982 16,354 5,880 7,734 80,796
Zoetis (ZTS) 60,799 51% 29.1 13% 11,272 8,594 6,150 3,124 1,461 2,252 65,484
Allergan (AGN) 54,957 63% -241.2 -5% 122,925 38,486 15,818 9,949 -5,872 -316 76,270
Sanofi (SNY) 52,845 0% 111,408 0 0 0 0 52,184
GW Pharmaceuticals (GWPH) 45,954 89% -870.1 -8% 848 128 205 182 -64 -52 45,400
Vertex Pharmaceuticals (VRTX) 43,431 87% 46.7 29% 7,515 2,261 3,620 3,135 2,144 857 40,027
Regeneron Pharmaceuticals (REGN) 32,266 0% 12.2 15% 13,939 3,435 7,622 0 2,144 2,539 30,869
Alexion Pharmaceuticals (ALXN) 23,581 92% 12.8 10% 14,815 4,448 4,736 4,359 1,470 1,874 23,912
Biomarin Pharmaceutical (BMRN) 12,700 79% 1,194.1 -1% 4,558 1,484 1,250 986 -39 11 13,147
Mylan (MYL) 10,768 34% 12.5 -0% 31,054 19,590 8,309 2,810 -4 1,882 23,458

Balance Sheet ($MM)2009-12-312010-04-042010-07-042010-10-032010-12-312011-04-032011-07-032011-10-022011-12-312012-04-012012-07-012012-09-302012-12-312013-03-312013-06-302013-09-292013-12-312014-03-302014-06-292014-09-282014-12-312015-03-292015-06-282015-09-272015-12-312016-04-032016-07-032016-10-022016-12-312017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-312019-03-312019-06-302019-09-29
Cash1,9781,7591,8772,1761,7357303,0963,7063,5392,9343,0314,50610,3892,1342,4362,0522,1832,8623,4062,4373,3433,5633,6703,0993,6412,5613,4112,0942,5954,0572,5852,7791,3422,4162,8113,6581,2252,0181,8372,846
Accounts Receivable14,64513,61114,01214,30214,61215,18215,19215,74913,60814,18212,88212,52312,37812,73511,52311,3719,3579,39910,3889,9558,6698,9208,9519,5358,1769,0339,1389,8368,2258,8929,47610,0028,2219,4529,87310,0248,0259,5999,7939,439
Inventory12,40310,1329,5118,7718,4058,4678,5978,4267,7697,1897,0017,5167,0637,0356,2826,4826,1666,0666,2496,3555,6635,7865,7967,6787,5137,5787,6147,5076,7837,4157,5847,9257,5788,1488,0748,1847,5088,0298,2338,222
PP&E22,78021,65120,04119,45032,29818,83318,28117,72130,52216,19214,75614,60627,88213,95012,44312,35925,67812,34712,17912,03224,98811,52711,43213,69527,26813,58413,60913,28428,12513,23813,38613,50530,03713,97113,91914,03629,97713,46713,52113,701
Assets212,949195,113191,071191,415195,014194,956195,899196,132188,002185,683182,842182,603185,798187,398179,335175,521172,101171,808172,612171,362169,274160,640160,878170,867167,460162,929170,658178,430171,615168,784168,558172,151171,797164,612164,980167,838159,422155,421156,199170,446
Accounts Payable4,3703,0283,0783,2064,0263,7503,6983,7653,8363,0913,1652,9674,2643,2791,9782,2873,2342,5462,9902,9733,4402,7242,9303,2943,6203,1253,2613,4764,5363,3933,4393,4804,6563,8794,1964,2974,6744,1564,0023,942
Long-Term Debt43,22038,28142,50044,80042,30038,70039,20040,10040,10038,60035,50036,50037,50037,80036,60036,40035,10032,60037,00031,66631,54129,37026,72929,07928,81827,82430,45730,43731,39836,33034,19134,50337,08436,59433,19737,90737,68540,20438,30738,475
Liabilities122,503105,031104,193103,347106,749104,423106,936105,602105,381102,006102,881100,488104,120104,571100,35897,16795,48193,74095,65693,05797,65293,05393,698103,743102,46399,582107,592114,829111,776110,038109,863111,041100,14194,07194,85696,17495,66496,26396,274105,051
Stockholders' Equity90,01489,65986,43987,63587,81390,06788,48190,04782,19083,25679,54781,70381,26082,25078,54777,96976,30777,76976,63377,98871,30167,30466,89466,83864,72063,06862,76963,30659,54458,43558,36860,77071,30870,18469,77871,31963,40758,80659,56865,103
Income Statement ($MM)2009-12-312010-04-042010-07-042010-10-032010-12-312011-04-032011-07-032011-10-022011-12-312012-04-012012-07-012012-09-302012-12-312013-03-312013-06-302013-09-292013-12-312014-03-302014-06-292014-09-282014-12-312015-03-292015-06-282015-09-272015-12-312016-04-032016-07-032016-10-022016-12-312017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-312019-03-312019-06-302019-09-29
Revenue16,75017,32716,17117,56116,50216,98417,19316,74615,40515,05713,97615,06813,50012,97312,64313,55811,35312,77312,36113,11810,86411,85312,08714,04713,00513,14713,04513,62812,77912,89613,16813,70312,90613,46613,29813,11813,26412,680
Cost of Revenue4,3063,7953,8964,2823,6933,8053,6793,9082,9742,7522,6653,1722,6522,2422,2872,7942,0452,9162,6942,4332,5762,602
Gross Profit12,44413,53212,27513,27912,80913,17913,51412,83812,43112,30511,31111,89610,84810,73110,35610,7649,30810,55010,60410,68510,68810,078
R&D2,2262,1872,1942,8062,0912,2372,1882,5962,0721,6991,9812,1361,8001,5301,6271,8111,6231,7591,8023,2091,8851,7341,7222,3481,7311,7481,8812,5121,7081,7801,8592,3111,7431,7972,0081,7031,8422,283
SG&A4,4364,8074,6335,7384,5034,9734,6215,3714,1333,9773,8474,8153,5853,5913,3954,1523,0403,5203,5563,9813,1043,3863,2705,0483,3853,4713,5594,4233,3083,4253,5004,5513,4123,5423,4943,3393,5113,260
Tax10,5471,4885642568941,0941,2358007501,2907685351,1601,7829851,0755821,082911545706905567-188535375284-718219267271,065556940469433-9153,047
Net Income2,0352,4858712,8902,2343,9663,7491,4391,8033,2603,2146,3152,76514,1342,5992,5682,3382,9212,6721,2282,3812,6352,139-1723,0262,0351,3208603,1303,0782,85812,2743,5703,8794,1223,8895,0567,684
Cash Flow ($MM)2009-12-312010-04-042010-07-042010-10-032010-12-312011-04-032011-07-032011-10-022011-12-312012-04-012012-07-012012-09-302012-12-312013-03-312013-06-302013-09-292013-12-312014-03-302014-06-292014-09-282014-12-312015-03-292015-06-282015-09-272015-12-312016-04-032016-07-032016-10-022016-12-312017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-312019-03-312019-06-302019-09-29
Cash Operating-6,3604,8736,6836,2584,6425,8984,4395,2612,7744,0215,0035,2562,2413,8305,9085,7862,9354,0874,4635,3986854,0905,0244,7131,6513,5794,6995,9721,5893,2524,8876,7421,9833,8475,2591,6982,6114,510
Cash Investing9,394-361-3,880-5,645725361215899451-887-2476,837-10,930836-61180-98-1,507-2,535-1,5146,592-2,105-5,243-2,2244,355-4,678-4,381-3,1074,772-1,738-2,996-4,7799,667-1,474-2,9047,550-1,902-6,760
Cash Financing-3,211-4,361-2,523-1,079-6,404-3,918-4,035-6,250-3,507-2,968-3,291-6,233434-4,034-5,631-5,744-2,133-2,040-2,887-2,926-6,982-1,875-267-1,109-7,0141,945-1,624-2,228-4,921-3,001-1,728-3,385-10,720-1,908-1,406-8,467-8513,273